<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9604935</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22377</journal-id>
<journal-id journal-id-type="nlm-ta">Addict Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Addict Biol</journal-id>
<journal-title-group>
<journal-title>Addiction biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1355-6215</issn>
<issn pub-type="epub">1369-1600</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29094432</article-id>
<article-id pub-id-type="pmc">5932272</article-id>
<article-id pub-id-type="doi">10.1111/adb.12576</article-id>
<article-id pub-id-type="manuscript">NIHMS911885</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mu opioid receptors in GABAergic neurons of the forebrain promote alcohol reward and drinking</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hamida</surname>
<given-names>Sami Ben</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN3">©</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boulos</surname>
<given-names>Laura-Joy</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN3">©</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McNicholas</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Charbogne</surname>
<given-names>Pauline</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kieffer</surname>
<given-names>Brigitte Lina</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">#</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Département de Médecine Translationnelle et Neurogénétique, Institut de Génétique et de Biologie Moléculaire et Cellulaire, INSERM U-964, CNRS UMR-7104, Université de Strasbourg, 67400 Illkirch-Graffenstaden, France</aff>
<aff id="A2">
<label>2</label>Douglas Research Center, Department of Psychiatry, Faculty of Medicine, McGill University, Montréal, H4H 1R3, Canada</aff>
<author-notes>
<corresp id="FN1"><label>#</label>Corresponding author: Brigitte L. Kieffer, PhD, Douglas Hospital Research Center, Perry Pavilion Room E-3317.1, 6875 boulevard LaSalle, Montreal (Quebec) H4H 1R3, Canada. Phone: 514 761-6131 ext: 3175 Fax: 514 762-3033. <email>brigitte.kieffer@douglas.mcgill.ca</email></corresp>
<fn fn-type="current-aff" id="FN2">
<label>3</label>
<p>Current position : Department of Neuroscience, School of Medicine, Brain Science Institute, Johns Hopkins University, Baltimore, MD, USA</p>
</fn>
<fn fn-type="equal" id="FN3">
<label>©</label>
<p>contributed equally to this work</p>
</fn>
<fn fn-type="COI-statement" id="FN5">
<p><bold>Disclosure/Conflict of Interest:</bold> The authors have no conflict of interest to disclose</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>02</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>24</volume>
<issue>1</issue>
<fpage>28</fpage>
<lpage>39</lpage>
<!--elocation-id from pubmed: 10.1111/adb.12576-->
<abstract>
<p id="P1">Mu opioid receptors (MORs) are widely distributed throughout brain reward circuits and their role in drug and social reward is well established. Substantial evidence has implicated MOR and the endogenous opioid system in alcohol reward, but circuit mechanisms of MOR-mediated alcohol reward and intake behavior remain elusive, and have not been investigated by genetic approaches. We recently created conditional knockout (KO) mice targeting the <italic>Oprm1</italic> gene in GABAergic forebrain neurons. These mice (Dlx-MOR KO) show a major MOR deletion in the striatum, whereas receptors in midbrain (including the Ventral Tegmental Area or VTA) and hindbrain are intact. Here, we compared alcohol-drinking behavior and rewarding effects in total (MOR KO) and conditional KO mice. Concordant with our previous work, MOR KO mice drank less alcohol in continuous and intermittent two-bottle choice protocols. Remarkably, Dlx-MOR KO mice showed reduced drinking similar to MOR KO mice, demonstrating that MOR in the forebrain is responsible for the observed phenotype. Further, alcohol-induced conditioned place preference was detected in control but not MOR KO mice, indicating that MOR is essential for alcohol reward and again, Dlx-MOR KO recapitulated the MOR KO phenotype. Taste preference and blood alcohol levels were otherwise unchanged in mutant lines. Together, our data demonstrate that MOR expressed in forebrain GABAergic neurons is essential for alcohol reward-driven behaviors, including drinking and place conditioning. Challenging the prevailing VTA-centric hypothesis, this study reveals another mechanism of MOR-mediated alcohol reward and consumption, which does not necessarily require local VTA MORs but rather engages striatal MOR-dpendent mechanisms.</p>
</abstract>
<kwd-group>
<kwd>mu opioid receptor</kwd>
<kwd>alcohol intake</kwd>
<kwd>forebrain GABAergic neurons</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>